Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

C3 antibody (Biotin)

The Mouse Monoclonal anti-C3 antibody has been validated for WB and EIA. It is suitable to detect C3 in samples from Human.
Catalog No. ABIN1106783

Quick Overview for C3 antibody (Biotin) (ABIN1106783)

Target

See all C3 Antibodies
C3 (Complement Component 3 (C3))

Reactivity

  • 109
  • 56
  • 37
  • 5
  • 5
  • 4
  • 3
  • 3
  • 2
  • 1
Human

Host

  • 84
  • 44
  • 36
  • 8
  • 7
  • 5
  • 1
Mouse

Clonality

  • 136
  • 48
Monoclonal

Conjugate

  • 85
  • 27
  • 22
  • 12
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This C3 antibody is conjugated to Biotin

Application

  • 117
  • 51
  • 45
  • 42
  • 37
  • 34
  • 32
  • 30
  • 29
  • 27
  • 22
  • 13
  • 13
  • 9
  • 5
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Enzyme Immunoassay (EIA)

Clone

474
  • Cross-Reactivity (Details)

    Species reactivity (tested):Human

    Purification

    Potein G

    Immunogen

    C3a

    Isotype

    IgG1
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    0.1 mg/mL

    Buffer

    PBS, 0.02 % sodium azide, 0.1 % bovine serum albumin

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Store at 2 - 8 °C.
  • Target

    C3 (Complement Component 3 (C3))

    Alternative Name

    Complement C3

    Background

    The complement system is an important factor in innate immunity. The third complement component, C3, is central to the classical, alternative and lectin pathways of complement activation. The synthesis of C3 is tissue-specific and is modulated in response to a variety of stimulatory agents. During complement activation, C3 is proteolytically cleaved resulting in release of the anaphylatoxic peptide C3a. C3a is a small polypeptide consisting of 74 amino acids (ca.10 kDa). C3a itself is very short-lived and in serum cleaved rapidly into the more stable C3a-desArg (also called acylation stimulating protein, ASP) . C3a exerts its function through a specific receptor (C3aR), which belongs to the G-protein coupled receptor family. Expression of C3aR has been reported in many cell types including myeloid and non-myeloid cells. Expression of C3aR on haematopoietic stem/progenitor cells has been shown to promote the trafficking/homing of these cells to the BM. Engagement of C3aR on DCs and T cells has been shown to up-regulate these cell functions. C3a is a mediator of local inflammatory processes. It induces smooth muscle contraction, increases vascular permeability, and causes histamine release from mast cells and basophilic leukocytes. C3a is involved in inflammatory reactions seen in gram-negative bacterial sepsis, trauma, ischemic heart disease, post-dialysis syndrome and a variety of autoimmune diseases. An inherited deficiency of C3 predisposes the person to frequent assaults of bacterial infections. In ulcerative colitis, and idiopathic chronic inflammatory bowel disease, the deposition of C3 in the diseased mucosa has been reported.Synonyms: C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1, CPAMD1, Complement component 3

    Gene ID

    9606

    UniProt

    P01024

    Pathways

    Complement System, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Regulation of G-Protein Coupled Receptor Protein Signaling
You are here:
Chat with us!